US Patent Issued to Societe des Produits Nestle on Nov. 4 for "Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section" (Danish Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,655, issued on Nov. 4, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section" was invented by Per Torp Sangild (Copenhagen NV, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising at least one human milk oligosaccharide and/or a precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants or young children born by C-section."

The patent was filed on Feb. 3, 2021, under Application No. 17/166,547.

*For further info...